Our community’s greatest unmet needs guide our funding priorities. Our latest community survey resulted in the planned expansion of the only current clinical trial in Kabuki syndrome.
Cross-institutional collaboration accelerates rare disease research. Our new Discovery Grant provides funding for the identification of 1+ new therapeutic opportunity through multi-institution collaboration.
KSF partners with institutions who understand that 100% of our funds need to go directly to projects that have an impact on our community.
